by Rakovina Therapeutics | Dec 2, 2025 | Uncategorized
DOWNLOAD Vancouver, British Columbia, November 28, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, announces that further to its news...
by Rakovina Therapeutics | Nov 24, 2025 | Uncategorized
DOWNLOAD Data highlights progress in Rakovina’s AI-derived PARP-1 inhibitor program Vancouver, British Columbia, November 24, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies...
by Rakovina Therapeutics | Nov 24, 2025 | Uncategorized
DOWNLOAD Variational AI’s Enki™ generative AI platform designed novel ATR/mTOR dual inhibitors with brain penetrance and activity in PTEN-deficient tumor models Vancouver, British Columbia, November 24, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”)...
by Rakovina Therapeutics | Nov 18, 2025 | Uncategorized
DOWNLOAD Vancouver, British Columbia, November 18, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, today announced that its President and...
by Rakovina Therapeutics | Nov 10, 2025 | Uncategorized
DOWNLOAD Vancouver, British Columbia, November 10, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, today announced that...
by Rakovina Therapeutics | Oct 27, 2025 | Uncategorized
PDF Version Vancouver, British Columbia, October 27, 2025 – Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) is pleased to announce the successful presentation of new data at the AACR-NCI-EORTC International Conference on Molecular...